246 related articles for article (PubMed ID: 11494160)
21. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection.
Mbulawa ZZ; Coetzee D; Marais DJ; Kamupira M; Zwane E; Allan B; Constant D; Moodley JR; Hoffman M; Williamson AL
J Infect Dis; 2009 May; 199(10):1514-24. PubMed ID: 19392625
[TBL] [Abstract][Full Text] [Related]
22. Effect of HIV infection on atypical squamous cells of undetermined significance.
Duerr A; Paramsothy P; Jamieson DJ; Heilig CM; Klein RS; Cu-Uvin S; Schuman P; Anderson JR;
Clin Infect Dis; 2006 Mar; 42(6):855-61. PubMed ID: 16477565
[TBL] [Abstract][Full Text] [Related]
23. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
24. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus.
Chin-Hong PV; Palefsky JM
Clin Infect Dis; 2002 Nov; 35(9):1127-34. PubMed ID: 12384848
[TBL] [Abstract][Full Text] [Related]
25. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women.
Palefsky JM
Semin Oncol; 2000 Aug; 27(4):471-9. PubMed ID: 10950374
[TBL] [Abstract][Full Text] [Related]
26. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.
Moscicki AB; Ellenberg JH; Farhat S; Xu J
J Infect Dis; 2004 Jul; 190(1):37-45. PubMed ID: 15195241
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV.
Fontaine J; Hankins C; Money D; Rachlis A; Pourreaux K; Ferenczy A; ; Coutlée F
J Clin Virol; 2008 Nov; 43(3):307-12. PubMed ID: 18786854
[TBL] [Abstract][Full Text] [Related]
28. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
29. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
30. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
31. Treatment of gynecological conditions in women.
Proj Inf Perspect; 1998 Sep; (25):15. PubMed ID: 11365842
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus-related tumors in HIV.
Palefsky J
Curr Opin Oncol; 2006 Sep; 18(5):463-8. PubMed ID: 16894294
[TBL] [Abstract][Full Text] [Related]
33. Markers of human papillomavirus infection and their correlation with cervical dysplasia in human immunodeficiency virus-positive women.
Riva E; Serraino D; Pierangeli A; Bambacioni F; Zaniratti S; Minosse C; Selleri M; Bucci M; Scagnolari C; Degener AM; Capobianchi MR; Antonelli G; Dianzani F;
Clin Microbiol Infect; 2007 Jan; 13(1):94-7. PubMed ID: 17184295
[TBL] [Abstract][Full Text] [Related]
34. Squamous intraepithelial lesions of the cervix, invasive cervical carcinoma, and immunosuppression induced by human immunodeficiency virus in Africa. Dyscer-CI Group.
La Ruche G; Ramon R; Mensah-Ado I; Bergeron C; Diomandé M; Sylla-Koko F; Ehouman A; Touré-Coulibaly K; Welffens-Ekra C; Dabis F
Cancer; 1998 Jun; 82(12):2401-8. PubMed ID: 9635533
[TBL] [Abstract][Full Text] [Related]
35. Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse.
Drobacheff C; Dupont P; Mougin C; Bourezane Y; Challier B; Fantoli M; Bettinger D; Laurent R
Eur J Dermatol; 2003; 13(4):367-71. PubMed ID: 12948917
[TBL] [Abstract][Full Text] [Related]
36. Effect of HIV viral load, CD4 cell count and antiretroviral therapy on human papillomavirus prevalence in urine samples of HIV-infected men.
Jong E; van Gorp EC; Mulder JW; Tol A; Smits PH
Int J STD AIDS; 2009 Apr; 20(4):262-4. PubMed ID: 19304972
[TBL] [Abstract][Full Text] [Related]
37. Editorial comment: issues with HIV and oral human papillomavirus infections.
Bonnez W
AIDS Read; 2002 Apr; 12(4):174-6. PubMed ID: 12071189
[No Abstract] [Full Text] [Related]
38. Cervico-vaginal dysplasia--papillomavirus-induced and HIV-1 infection: role of correlated markers for prognostic evaluation.
Pugliese A; Andronico L; Gennero L; Pagliano G; Gallo G; Torre D
Cell Biochem Funct; 2002 Sep; 20(3):233-6. PubMed ID: 12125100
[TBL] [Abstract][Full Text] [Related]
39. Association of human papillomavirus infection and disease with magnitude of human immunodeficiency virus type 1 (HIV-1) RNA plasma level among women with HIV-1 infection.
Luque AE; Demeter LM; Reichman RC
J Infect Dis; 1999 Jun; 179(6):1405-9. PubMed ID: 10228061
[TBL] [Abstract][Full Text] [Related]
40. The impact of the human immunodeficiency virus on the human papillomavirus epidemic.
Chopra KF; Tyring SK
Arch Dermatol; 1997 May; 133(5):629-33. PubMed ID: 9158417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
